LH Q1 Earnings Call: Labcorp Grows Revenue but Misses Expectations, Raises Adjusted EPS Guidance
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) missed Wall Street's revenue expectations in Q1 CY2025, but sales rose 5.3% year on year to $3.35 billion. Its non-GAAP profit of $3.84 per share was 2.8% above analysts' consensus estimates.
Is now the time to buy LH? Find out in our full research report (it's free).
Revenue: $3.35 billion vs analyst estimates of $3.41 billion (5.3% year-on-year growth, 1.9% miss)
Adjusted EPS: $3.84 vs analyst estimates of $3.73 (2.8% beat)
Adjusted EBITDA: $560.6 million vs analyst estimates of $577.1 million (16.8% margin, 2.9% miss)
Management slightly raised its full-year Adjusted EPS guidance to $16.05 at the midpoint
Operating Margin: 9.7%, in line with the same quarter last year
Free Cash Flow was -$107.5 million compared to -$163.6 million in the same quarter last year
Organic Revenue rose 2.1% year on year, in line with the same quarter last year
Market Capitalization: $21 billion
Labcorp's first quarter results reflected higher demand in its core diagnostics business, as management pointed to a rebound in test volumes after weather disruptions earlier in the quarter. CEO Adam Schechter cited ongoing growth in the company's managed care contracts and successful integration of recent acquisitions as factors supporting revenue. Schechter also highlighted the launch of new tests in oncology, women's health, autoimmune disease, and neurology as helping Labcorp capture more patient volume in high-growth therapeutic areas.
Looking ahead, Labcorp slightly raised its full-year adjusted EPS guidance, with management confident in margin expansion through cost savings and operational efficiencies. Julia Wang, CFO, explained that guidance now factors in potential tariff impacts and ongoing regulatory uncertainty, but benefits from the company's expense control initiatives and supply chain flexibility. Schechter emphasized the company's ability to offset rising personnel costs and external headwinds, stating, 'We think we'll be able to offset the impacts from tariffs.'
Labcorp's management focused on business execution, segment momentum, and adapting to a changing regulatory and macroeconomic environment.
Diagnostics volume recovery: The diagnostics segment benefitted from a rebound in test volumes after weather-related softness early in the quarter, with organic growth improving when adjusted for these headwinds.
Integration of Invitae acquisition: Management reported Invitae is on track to deliver over 10% revenue growth and become slightly accretive to earnings for the full year. The integration is progressing better than anticipated, and the acquisition is seen as a key contributor to growth in high-potential areas such as oncology and women's health.
New test launches and innovation: Labcorp introduced several new tests, including a liquid biopsy for personalized cancer treatment and a blood-based biomarker for Alzheimer's disease. These offerings are expected to help Labcorp expand in faster-growing therapeutic segments.
Operational efficiency initiatives: The company continues to drive savings through its LaunchPad program and the rollout of digital tools, such as eClaim Assist for billing and a diagnostics assistant for providers, aimed at improving both margins and customer experience.
Tariff and regulatory planning: Management discussed contingency planning for various tariff and regulatory scenarios, emphasizing that supply chain flexibility and long-term contracts with U.S. suppliers help minimize risks. The company's guidance range incorporates what it views as the most likely macroeconomic and policy scenarios.
Labcorp's outlook for the remainder of the year emphasizes margin improvement, continued acquisition integration, and resilience to external pressures, with a focus on high-growth testing categories.
Continued product and test expansion: Management expects new test launches, especially in oncology and neurology, to drive above-market growth. The focus is on expanding test menus that meet unmet clinical needs and attract new customer segments.
Cost management and operational leverage: The LaunchPad cost savings program and adoption of digital workflow tools are anticipated to offset inflationary pressures, including rising personnel costs and potential tariff impacts.
Regulatory and payer landscape: Ongoing monitoring of U.S. policy changes such as PAMA (Protecting Access to Medicare Act) and new tariffs remains a risk, but management believes that diversified payer contracts and contingency planning will support stable performance.
Michael Cherny (Leerink Partners): Asked about volatility in biopharma laboratory services and the impact of regulatory changes. Management said the guidance range reflects possible study delays but has not seen significant disruptions so far.
Ann Hynes (Mizuho): Inquired about the degree to which tariffs are now incorporated into guidance. CEO Adam Schechter explained that most supply contracts are U.S.-based and multi-year, so tariff exposure is limited and manageable.
Erin Wright (Morgan Stanley): Sought clarity on the split between organic and acquisition-driven growth in diagnostics, as well as the impact of weather. CFO Julia Wang clarified that, adjusted for weather, organic growth was consistent with historical trends.
Lisa Gill (JP Morgan): Asked about the regulatory outlook for animal testing in early development. Schechter estimated this is 10–15% of the biopharma segment's revenue and does not expect a major impact this year.
Jack Meehan (Nephron Research): Pressed for details on Invitae's trajectory toward accretion. Management reported integration is proceeding well, with cost savings expected to make Invitae slightly accretive to earnings by year-end.
In the coming quarters, the StockStory team will be watching (1) progress in integrating acquisitions such as Invitae and the resulting impact on margins, (2) the launch and adoption of new high-growth diagnostic tests—particularly in oncology and neurology, and (3) management's ability to offset inflationary and tariff headwinds through operational efficiency programs. The evolution of the regulatory landscape and updates on Labcorp's business development pipeline will also be important signposts for tracking the company's execution.
Labcorp currently trades at a forward P/E ratio of 15.2×. Should you double down or take your chips? Find out in our free research report.
Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Supplement Your Paycheck by Investing in These High-Yield Monthly Dividend Stocks
Realty Income has increased its monthly dividend 130 times since coming public in 1994. SL Green Realty has started increasing its monthly dividend as demand for office space recovers. Healthpeak Properties recently switched to paying monthly dividends. 10 stocks we like better than Realty Income › If you're like most people, you probably wish your paycheck was a bit bigger. That would give you more money to save for a rainy day, invest for retirement, or spend on things you want. There are many ways to supplement your income, most of which require time or money. If you have some extra cash lying around, you can use it to generate passive income. Here are a few high-yielding dividend stocks that make monthly payments, which can help supplement your paycheck. Realty Income (NYSE: O) is one of the most bankable monthly dividend stocks you'll find. The real estate investment trust (REIT) has paid 659 monthly dividends since its formation. The REIT currently pays $0.2685 per share each month, or $3.222 annualized. The company has a nearly 5.8% dividend yield at its recent stock price. At that rate, every $100 invested in the stock would produce about $0.48 of dividend income each month and $5.80 per year. The more money you invest, the more income you collect. The great thing about Realty Income is that it routinely raises its dividend payment. The REIT has increased its dividend 130 times since coming public in 1994, and for the past 110 quarters in a row. The main factor driving Realty Income's steadily rising dividends is acquisitions. The REIT has a strong financial profile, with a low 75% dividend payout ratio, and its balance sheet looks just as good. It's one of only 10 REITs in the S&P 500 with two bond ratings of A3/A- or higher. That gives it the financial flexibility to continue investing in properties including net lease retail, industrial, gaming, and others that generate stable rental income to support its growing dividend. SL Green Realty (NYSE: SLG) is the largest office landlord in Manhattan. While demand for office space has declined since the pandemic, it has been slowly recovering. Demand for high-quality office space has been strongest, which is benefiting SL Green Realty because it owns some of the best office buildings in the City. For example, occupancy across its portfolio was 91.8% at the end of March and should improve to 93.2% by year-end as tenants that recently signed leases move into their space this year. As a result, the office REIT's rental income is starting to grow. That enabled it to raise its dividend for 2025 to a monthly rate of $0.2575 per share, or $3.09 annualized, up from $3.00 last year, giving it a 5.3% dividend yield at its recent share price. SL Green only expects to pay out about 57% of its cash flow in dividends this year. That's enabling it to retain money to invest in new properties. Those new investments position the REIT to grow its rental income, which should support future dividend increases. Healthpeak Properties (NYSE: DOC) is a healthcare REIT. It owns a diversified portfolio of outpatient medical buildings, life science properties, and senior housing communities. This portfolio provides it with steadily growing rental income to support its dividend payment. The REIT just switched to a monthly dividend schedule in April, setting the rate at $0.10167 per share, or $1.22 annualized. That's a 1.7% increase from its dividend payment last year. Healthpeak currently has a 7% dividend yield at its recent share price. The healthcare landlord produces more than enough cash to cover its dividend payment. It also has a solid balance sheet, enough so that Healthpeak Properties estimates it has between $500 million and $1 billion of dry powder to make acquisitions or repurchase its shares. Deploying that capital into accretive opportunities should grow its cash flow per share, which should enable the REIT to continue increasing its monthly dividend in the future. Realty Income, SL Green Realty, and Healthpeak Properties pay monthly dividends. These REITs are in solid positions to continue increasing their high-yielding dividend payments in the future. Buying their shares should supply you with growing streams of passive income to help supplement your monthly paycheck. Before you buy stock in Realty Income, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Realty Income wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,761!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $826,263!* Now, it's worth noting Stock Advisor's total average return is 978% — a market-crushing outperformance compared to 170% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Matt DiLallo has positions in Realty Income and SL Green Realty. The Motley Fool has positions in and recommends Realty Income. The Motley Fool recommends Healthpeak Properties. The Motley Fool has a disclosure policy. Supplement Your Paycheck by Investing in These High-Yield Monthly Dividend Stocks was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Herc Holdings and H&E Equipment Services Announce Expiration of the Tender Offer to Acquire Shares of H&E Equipment Services and Expected Closing Date
BONITA SPRINGS, Fla. and BATON ROUGE, La., May 30, 2025 (GLOBE NEWSWIRE) -- Herc Holdings Inc. (NYSE: HRI) ('Herc' or 'the Company') and H&E Equipment Services, Inc. d/b/a H&E Rentals (NASDAQ: HEES) ('H&E') announced today the expiration of the tender offer to exchange each outstanding share of H&E common stock (the 'H&E Shares') for $78.75 in cash and 0.1287 shares of Herc common stock, in each case without interest (the 'Offer', and such consideration, the 'Offer Price'), pursuant to the terms of the previously announced merger agreement, dated February 19, 2025, between Herc, HR Merger Sub Inc. ('Merger Sub') and H&E (the 'Merger Agreement'). The Offer, which was extended on May 23, 2025, expired at one minute past 11:59 p.m. Eastern Time on May 29, 2025. The Depository and Paying Agent for the Offer has advised Herc that as of the expiration of the Offer, a total of 25,369,090 H&E Shares were validly tendered and not validly withdrawn in the Offer, representing approximately 69.33% of the outstanding H&E Shares. As of such expiration, all conditions to the Offer have been satisfied or waived and Merger Sub has accepted for payment all H&E Shares validly tendered and not validly withdrawn in accordance with the terms of the Offer (the 'Tendered Shares'). Herc, Merger Sub and H&E currently expect to close the acquisition on June 2, 2025. At the closing, Herc and Merger Sub will pay for all of the Tendered Shares. Additionally, the parties will consummate the merger of Merger Sub with and into H&E (the 'Merger'). As a result of the Merger, all of the H&E Shares other than the Tendered Shares will be converted into the right to receive the Offer Price in accordance with the terms of the Merger Agreement. As a result of the Offer and the Merger, H&E will become a wholly-owned subsidiary of Herc and H&E Shares will cease trading on the Nasdaq Stock Market. About Herc Holdings Inc. Founded in 1965, Herc Holdings Inc., which operates through its Herc Rentals Inc. subsidiary, is a full-line rental supplier with 453 locations across North America, and 2024 total revenues of approximately $3.6 billion. We offer products and services aimed at helping customers work more efficiently, effectively, and safely. Our classic fleet includes aerial, earthmoving, material handling, trucks and trailers, air compressors, compaction, and lighting equipment. Our ProSolutions® offering includes industry-specific, solutions-based services in tandem with power generation, climate control, remediation and restoration, pumps, and trench shoring equipment as well as our ProContractor professional grade tools. We employ approximately 7,600 employees, who equip our customers and communities to build a brighter future. Learn more at and follow us on Instagram, Facebook and LinkedIn. About H&E Equipment Services, Inc. Founded in 1961, H&E is one of the largest rental equipment companies in the nation. H&E's fleet is comprised of aerial work platforms, earthmoving, material handling, and other general and specialty lines. H&E serves a diverse set of end markets in many high-growth geographies and has branches throughout the Pacific Northwest, West Coast, Intermountain, Southwest, Gulf Coast, Southeast, Midwest and Mid-Atlantic regions. Cautionary Note Regarding Forward Looking Statements This communication includes 'forward-looking statements,' within the meaning of Section 21E of the Securities Exchange Act, as amended. Forward-looking statements include statements related to the Company, H&E and the proposed acquisition of H&E by the Company that involve substantial risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements in this communication include, among other things, statements about the potential benefits of the proposed transaction, the Company's plans, objectives, expectations and intentions, the financial condition, results of operations and business of each of the Company and H&E, expected valuation and re-rating opportunities for the combined company, and the anticipated timing of closing of the proposed transaction. Forward-looking statements are generally identified by the words 'estimates,' 'expects,' 'anticipates,' 'projects,' 'plans,' 'intends,' 'believes,' 'forecasts,' 'looks,' and future or conditional verbs, such as 'will,' 'should,' 'could' or 'may,' as well as variations of such words or similar expressions. All forward-looking statements are based upon our current expectations and various assumptions and apply only as of the date of this communication. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that our expectations, beliefs and projections will be achieved or that the completion and anticipated benefits of the proposed transaction can be guaranteed, and actual results may differ materially from those projected. You should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from those suggested by our forward-looking statements, including, but not limited to, (i) the Company's ability to implement its plans, forecasts and other expectations with respect to H&E's business after the completion of the proposed transaction and realized expected synergies; (ii) the ability to realize the anticipated benefits of the proposed transaction, including the possibility that the expected benefits from the proposed transaction will not be realized or will not be realized within the expected time period; (iii) the length of time necessary to consummate the proposed transaction may be longer than anticipated; (iv) problems may arise in successfully integrating the businesses of the Company and H&E, including, without limitation, problems associated with the potential loss of any key employees, customers, suppliers and other counterparties of H&E (v) the proposed transaction may involve unexpected costs, including, without limitation, the exposure to any unrecorded liabilities or unidentified issues during the due diligence investigation of H&E or that are not covered by insurance, as well as potential unfavorable accounting treatment and unexpected increases in taxes; (vi) the Company's business may suffer as a result of uncertainty surrounding the proposed transaction, any adverse effects on our ability to maintain relationships with customers, employees and suppliers; (vii) the occurrence of any event, change to other circumstances that could give rise to the termination of the merger agreement, the failure of the closing conditions included in the merger agreement to be satisfied, or any other failure to consummate the proposed transaction; (viii) any negative effects of the announcement of the proposed transaction of the financing thereof on the market price of the Company common stock or other securities; (ix) the industry may be subject to future risks including those set forth in the 'Risk Factors' section in the Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and in the other filings with the SEC by each of the Company and H&E and (xi) Herc may not achieve its valuation or re-rating opportunities. The foregoing list of factors is not exhaustive. Investors should carefully consider the foregoing factors and the other risks and uncertainties that affect the businesses of the Company and H&E, including those described in the Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and in the other filings with the SEC by each of the Company and H&E. All forward-looking statements are expressly qualified in their entirety by such cautionary statements. We undertake no obligation to update or revise forward-looking statements that have been made to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. Contacts For Herc Holdings Inc.: Leslie HunzikerSenior Vice PresidentInvestor Relations, Communications & For H&E Equipment Services, Inc.: Leslie S. MageeChief Financial Officer225-298-5261lmagee@ Jeffrey L. ChastainVice President of Investor Relations225-952-2308jchastain@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Dell Shares Climb After Raising Profit Outlook on AI Boom
May 30 - Shares of Dell Technologies (NYSE:DELL) climbed about 2% in Friday premarket trading after the company lifted its full-year profit outlook and issued stronger-than-expected guidance for the current quarter. In fiscal first quarter, Dell posted adjusted EPS of $1.55, below LSEG's $1.69 estimate, but revenue rose 1% above forecasts at $23.38 billion versus $23.14 billion expected. For the current quarter, management sees adjusted EPS of $2.25 and revenue between $28.5 billion and $29.5 billion, comfortably above consensus projections. Executives attributed the upbeat guidance to unprecedented demand for AI systems, including $7 billion in AI hardware slated to ship this quarter. Dell's Infrastructure Solutions Group, which houses its server and networking business, generated $10.3 billion in Q1 revenue, up 12% year-over-year, driven largely by AI-focused orders. On the full-year front, Dell maintained its revenue forecast of about $103 billion but raised adjusted EPS guidance by ten cents to $9.40. The company also highlighted a $14.4 billion backlog of confirmed AI system orders, up from $12.1 billion in Q1, which it expects to convert into revenue over the coming quarters. Based on the one year price targets offered by 19 analysts, the average target price for Dell Technologies Inc is $129.92 with a high estimate of $156.00 and a low estimate of $95.00. The average target implies a upside of +14.33% from the current price of $113.63. Based on GuruFocus estimates, the estimated GF Value for Dell Technologies Inc in one year is $76.84, suggesting a downside of -32.38% from the current price of $113.63. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
